Table 1. Socio-demographic and clinical variables of the study population.
| Parameter | Total patients (n=56) | |
|---|---|---|
| Gender, n (%) | ||
| Male | 37 (66%) | |
| Female | 19 (34%) | |
| Mean age (SD) years | 57.4 ± 11.4 | |
| Treatment received | ||
| SOF + DAC ± RBV | 38 (67.8%) | |
| SOF + SMV ± RBV | 17 (30.3%) | |
| SOF + RBV | 1 (1.7%) | |
| Time since diagnosis, years (SD) | 10.87 ± 9.67 | |
| Genotype | ||
| 1 | 42 (75%) | |
| 2 | 1 (1.7%) | |
| 3 | 13 (23.2%) | |
| Treatment duration | ||
| 12 w | 44 (78.5%) | |
| 24 w | 12 (21.5%) | |
| Metavir | ||
| NI | 15 (26.7%) | |
| F2 | 9 (16%) | |
| F3 | 15 (26.7%) | |
| F4 | 17 (30.3%) | |
| Patients previously treated | 35 (62%) | |
| Viral load ≥ 800.000 IU mL-1 | 27 (48%) | |
| Race | ||
| White | 41 (73.2%) | |
| Black | 5 (9%) | |
| Others | 10 (17%) | |
| Marital status | ||
| Married | 31 (55%) | |
| Single | 10 (17.8%) | |
| Separated | 10 (17.8%) | |
| Widowed | 5 (9%) | |
| Educational level | ||
| Illiterate | 1 (1.7%) | |
| Elementary school | 8 (14.2%) | |
| Secondary school | 29 (51%) | |
| High school | 18 (32%) | |
| Patients with other comorbidities | 33 (59%) | |
| Patients with addictions | 16 (28%) | |
Abbreviations: NI: not informed; RBV: ribavirin; SOF: sofosbuvir; SMV: simeprevir